You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Mendeley readers
Attention Score in Context
| Title |
A cost-effectiveness analysis of artemether lumefantrine for treatment of uncomplicated malaria in Zambia
|
|---|---|
| Published in |
Malaria Journal, February 2007
|
| DOI | 10.1186/1475-2875-6-21 |
| Pubmed ID | |
| Authors |
Pascalina Chanda, Felix Masiye, Bona M Chitah, Naawa Sipilanyambe, Moonga Hawela, Patrick Banda, Tuoyo Okorosobo |
| Abstract |
Malaria remains a leading cause of morbidity, mortality and non-fatal disability in Zambia, especially among children, pregnant women and the poor. Data gathered by the National Malaria Control Centre has shown that recently observed widespread treatment failure of SP and chloroquine precipitated a surge in malaria-related morbidity and mortality. As a result, the Government has recently replaced chloroquine and SP with combination therapy as first-line treatment for malaria. Despite the acclaimed therapeutic advantages of ACTs over monotherapies with SP and CQ, the cost of ACTs is much greater, raising concerns about affordability in many poor countries such as Zambia. This study evaluates the cost-effectiveness analysis of artemether-lumefantrine, a version of ACTs adopted in Zambia in mid 2004. |
Mendeley readers
The data shown below were compiled from readership statistics for 85 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 1 | 1% |
| Belgium | 1 | 1% |
| South Africa | 1 | 1% |
| Brazil | 1 | 1% |
| Unknown | 81 | 95% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Master | 21 | 25% |
| Student > Ph. D. Student | 13 | 15% |
| Researcher | 12 | 14% |
| Student > Bachelor | 9 | 11% |
| Student > Postgraduate | 7 | 8% |
| Other | 14 | 16% |
| Unknown | 9 | 11% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 33% |
| Social Sciences | 14 | 16% |
| Economics, Econometrics and Finance | 8 | 9% |
| Pharmacology, Toxicology and Pharmaceutical Science | 7 | 8% |
| Agricultural and Biological Sciences | 6 | 7% |
| Other | 12 | 14% |
| Unknown | 10 | 12% |
Attention Score in Context
This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 26 March 2018.
All research outputs
#4,394,846
of 23,743,910 outputs
Outputs from Malaria Journal
#1,099
of 5,697 outputs
Outputs of similar age
#13,302
of 77,654 outputs
Outputs of similar age from Malaria Journal
#2
of 17 outputs
Altmetric has tracked 23,743,910 research outputs across all sources so far. Compared to these this one has done well and is in the 80th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 5,697 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.8. This one has done well, scoring higher than 80% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 77,654 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 81% of its contemporaries.
We're also able to compare this research output to 17 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 88% of its contemporaries.